Single award · grant
Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of…
Award ID: R01AG065248
FY2020 · complete year · data as of 2026-07-12
A single federal award, with both ends of the trail linked.
$80.7M
Total award value
Award R01AG065248 is a grant from the Department of Health and Human Services, $80.7M obligated, FY2020 to FY2027, for Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and…. The work is performed in Pennsylvania. Source
Description
Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease Over 18 Months
Award details
Award typeGrant
FAINR01AG065248
Action date2020
Period84 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performancePennsylvania →
Category—
Competed?Not recordedSource
Total (exact)$80,730,785
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.